Darren Fegley
United States Food and Drug Administration(US)
Publications by Year
Research Areas
Cannabis and Cannabinoid Research, Forensic Toxicology and Drug Analysis, Neurotransmitter Receptor Influence on Behavior, Sleep and Wakefulness Research, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Modulation of anxiety through blockade of anandamide hydrolysis(2002)1,279 cited
- → An endocannabinoid mechanism for stress-induced analgesia(2005)763 cited
- → Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation(2005)428 cited
- → Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus(2005)236 cited
- → Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172(2004)232 cited
- → Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors(2005)192 cited
- → Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia(2005)80 cited
- → Increased fear‐ and stress‐related anxiety‐like behavior in mice lacking tuberoinfundibular peptide of 39 residues(2008)46 cited
- → Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients(2017)39 cited
- → Erratum: Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus(2006)23 cited